NCT00000319View on ClinicalTrials.gov

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

PHASE2CompletedINTERVENTIONAL

0

Timeline

Start Date

June 30, 1996

Study Completion Date

January 31, 2005

Conditions

Opioid-Related DisordersSubstance-Related Disorders

Interventions

DRUG

Buprenorphine

Trial Locations (1)

06519

APT Residential Services Division, New Haven

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER